Shire has acquired Meritage, a privately-held company, for an upfront fee of $70 million and additional contingent payments based on the achievement of development and regulatory milestones.
Jacobs Engineering Group has received a contract from Bristol-Myers Squibb Company to provide architectural and engineering services for a new large-scale biologics manufacturing facility in Cruiserath, County Dublin, Ireland.
The Hazardous Location Series Air Conditioners for electrical enclosures are designed for use in NEC Class I, Division 1 Groups A, B, C & D and Division 2 Groups A, B, C & D locations in conjunction with types X and Z purged enclosures, these units are used where hazardous gases are or may be present, and are also suitable for corrosive environments.
Sagent Pharmaceuticals has announced the voluntary nationwide recall of two lots of Atracurium Besylate Injection, USP, 50mg/5mL single-dose vials (NDC 25021-659-05) and four lots of Atracurium Besylate Injection, USP, 100mg/10mL multi-dose vials (NDC 25021-672-10) manufactured by Emcure Pharmaceuticals Ltd. and distributed by Sagent.
Far fewer veterans than expected are taking advantage of a new law aimed at making it easier for them to get private health care and avoid the long waits that have plagued Department of Veterans Affairs facilities nationwide.
Millions of people could lose health insurance subsidies in the coming months if the Supreme Court sides with opponents of President Barack Obama's health care overhaul. And one thing was clear this weekend as the nation's governors gathered in Washington: Many of the states that could be affected are not prepared for the potential fallout.
America's biggest tobacco companies say they are ready and willing to pass along factual public health information about cigarettes. But they say they will not go along with being forced to underwrite an ad campaign that would have the companies brand themselves as liars.
Baxter International announced today that Baxalta Incorporated, the biopharmaceutical company that is expected to separate from Baxter in mid-2015, will be headquartered in Northern Illinois at 1200 Lakeside Drive, Bannockburn, IL.
One is a businesswoman and an MBA graduate. Another is a corporate vice president. The third is a registered nurse. These three mothers — all of them educated, middle-class professionals — are among the vaccine skeptics who have been widely ridiculed since more than 100 people fell ill in a measles outbreak traced to Disneyland.
Valeant Pharmaceuticals International Inc. has agreed to buy Salix Pharmaceuticals Ltd. for about $10 billion in cash. The companies said Sunday that their boards of directors approved the transaction, which amounts to about $158 for each of Salix's outstanding shares.
Alkermes has appointed Mark Namchuk, Ph.D., as Senior Vice President of Research, Pharmaceutical and Nonclinical Development. Dr. Namchuk will be responsible for advancing the company’s early-stage product pipeline.
NGM Biopharmaceuticals, Inc., a privately-held biotechnology company and Merck announced they have entered into a multi-year collaboration to research, discover, develop and commercialize novel biologic therapies across a wide range of therapeutic areas.
Mylan announced that its Indian subsidiary, Mylan Pharmaceuticals Private Limited, has entered into an agreement with Gilead Sciences, under which Mylan has been appointed as the exclusive distributor of Sovaldi and Harvoni for the treatment of chronic hepatitis C, in India.
Bristol-Myers Squibb and Flexus Biosciences announced today the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all of the outstanding capital stock of Flexus, a privately held biotechnology company focused on the discovery and development of novel anti-cancer therapeutics.
An 18-year-old student is struggling to survive after he was infected by a "superbug" outbreak tied to contaminated medical instruments at a Los Angeles hospital, his attorney said.